The Gut Microbiota’s Impact on the Emergence and Development of Neurodegenerative Diseases

An intricate community of microorganisms living in the gastrointestinal tract, known as the gut microbiota, has come to be recognised as a vital component of human health, impacting a range of physiological functions such as metabolism and immunological response. The possible influence of gut microbiota on the development and course of neurodegenerative illnesses, including multiple sclerosis, Parkinson's disease, and Alzheimer's disease, has been brought to light by recent research. Dysbiosis, defined by alterations in the makeup of the gut microbiota, has been connected to the emergence of neurodegenerative illnesses. There are several pathways that facilitate bilateral interaction between the GIT and the brain, including metabolites produced by gut bacteria and neurotransmitters. In addition, research is being done on probiotics and dietary modifications as possible therapeutic approaches to rebalance microbes and slow the progression of neurodegenerative diseases. <br>This chapter investigates the complex connection between human health and gut bacteria, particularly focusing on how it influences neurodegenerative illnesses. The composition of the gut microbiome is emphasised, as is how it affects brain function through the gut-brain axis. This chapter also includes intriguing preclinical and clinical data on prospective treatment techniques that target the gut microbiota, such as antibiotics, probiotics, and prebiotics, along with fecal microbiota transplantation. All things considered, this work highlights the importance of gut microbiota in relation to neurodegenerative diseases and the necessity of comprehending and treating the gutbrain axis in future therapeutic approaches.&nbsp;